Cite
HARVARD Citation
Fenerty, K. et al. (2018). Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition. Journal for immunotherapy of cancer. 6 (1), p. . [Online].